Showing results (91-100 of 150) with videos related to

Sort By:
Pageof 15
Experimental Hematology & Oncology|May 14, 2025
Epstein-Barr virus infection following allogeneic hematopoietic stem cell transplantation in the era of letermovir for cytomegalovirus prophylaxisJingtao Huang, Jing Zhou, Shixuan Zhang, et al.
International Journal of Oncology|March 25, 2017
Hydroxychloroquine sensitizes chronic myeloid leukemia cells to Vγ9Vδ2 T cell-mediated lysis independent of autophagyBiqing Han, Yanmin Zhao, Yu Lin, et al.
Bone Marrow Transplantation|June 27, 2024
Risk factors and long-term outcomes for human herpesvirus 6 encephalitis in the early period after allogeneic stem cell transplantationYi Yu, Weihao Chen, Huarui Fu, et al.
American Journal of Hematology|June 9, 2020
Ruxolitinib combined with etanercept induce a rapid response to corticosteroid-refractory severe acute graft vs host disease after allogeneic stem cell transplantation: Results of a multi-center prospective studyYanmin Zhao, Hengwei Wu, Jimin Shi, et al.
The Lancet Regional Health. Western Pacific|July 28, 2026
Low-dose chidamide maintenance therapy following allogeneic hematopoietic cell transplantation in T-cell acute lymphoblastic leukemia or lymphomas: a phase II, open-label, multicenter, single-arm trialYanmin Zhao, Weihao Chen, Yi Yu, et al.
Leukemia Research|March 1, 2011
Imatinib combined with myeloablative allogeneic hematopoietic stem cell transplantation for advanced phases of chronic myeloid leukemiaYi Luo, Yanmin Zhao, Yamin Tan, et al.
Annals of Hematology|March 2, 2024
Outcomes of haploidentical peripheral blood stem cell transplantation following myeloablative conditioning using two types of rabbit ATG: a propensity score-matched analysisZhuoyue Shi, Fei Gao, Dang Ding, et al.
Clinical & Translational Immunology|January 15, 2024
Graft CD8 T-cell-based risk system predicts survival in antithymocyte globulin-based myeloablative haploidentical peripheral blood stem cell transplantationPanpan Zhu, Luxin Yang, Yibo Wu, et al.
International Journal of Hematology|April 8, 2009
Efficacy and prognosis of chronic myeloid leukemia treated with imatinib mesylate in a Chinese populationYanmin Zhao, Lizhen Liu, Yingjia Wang, et al.
Bone Marrow Transplantation|June 17, 2020
Correction: Allogeneic hematopoietic stem cell transplantation should be in preference to conventional chemotherapy as post-remission treatment for adults with lymphoblastic lymphomaLuxin Yang, Yamin Tan, Jimin Shi, et al.
Pageof 15